Does Medicare pay for acupuncture?

Translate to Spanish or other 102 languages!

Medicare Part B currently funds up to 12 sessions of acupuncture treatment for those with chronic lower back pain. Image for illustration purposes
Medicare Part B currently funds up to 12 sessions of acupuncture treatment for those with chronic lower back pain. Image for illustration purposes
- Advertisement -

Medical News Today

According to the National Center for Complementary and Integrative HealthTrusted Source, acupuncture can help soothe neck and lower back pain and discomfort due to osteoarthritis and knee pain. 

People might also benefit from the effects of acupuncture if they have migraine headaches. 

- Advertisement -

Medicare Part B currently funds up to 12 sessions of acupuncture treatment for those with chronic lower back pain. The insured individual will need to pay 20% of the fee that Medicare approves for coverage.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/does-medicare-cover-acupuncture?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-06-05&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -